• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Getinge iCast Receives FDA Premarket Approval

    Tessy Plastics Corp. Celebrates 50th Anniversary

    Carium Expands Customization Options with Care Pathways

    InBody Supplying U.S. Marine Corps With Body Composition Analysis Devices

    Blackford and Brainomix Collaborate to Improve Stroke Care
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    CR-SOP Neurotechnology Helps to Achieve ‘Sound’ Sleep

    Inside the Hospital Value Analysis Committee

    Face Time: Why Getting Engineers Out of the Lab Is Good for Business

    Common Paratubing Pitfalls and How to Avoid Them

    During Times of Uncertainty, Create Business Value with an Optimized Workforce
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment

    Sourcing Silicone Parts: Injection Mold or 3D Print?

    Cybersecurity in Healthcare: Getting on the Right Track
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences

    Product will help provide a more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago.

    FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences
    Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.
    Business Wire09.12.19
    Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes.
     
    Qlarity Imaging will further develop QuantX, the first-ever U.S. Food and Drug Administration (FDA)-cleared computer-aided breast cancer diagnosis system in radiology. Qlarity plans to expand the diagnostic applications of its AI technology to additional image modalities and medical conditions, with the goal of improving patient care while lowering costs for hospitals and payers.
     
    Qlarity Imaging acquired QuantX, the medical imaging AI system with intuitive displays, advanced analytics, and machine learning, initially developed at the University of Chicago based on research led by Dr. Maryellen L. Giger, and incubated at Quantitative Insights, a startup that had been launched with the support of the University of Chicago’s Polsky Center for Entrepreneurship and Innovation. A clinical study demonstrated the effectiveness of QuantX at helping radiologists interpret cancerous and non-cancerous breast lesions, leading to a 39 percent reduction in missed breast cancers without a reduction in specificity, as well as a 20 percent overall diagnostic improvement. The study led to the FDA clearance of the AI technology for breast cancer.
     
    “By driving innovation across life sciences, Paragon fulfills its mission of improving outcomes for patients with severe medical conditions. So, we’re pleased to help further develop the first FDA-cleared, artificial intelligence-enabled diagnostic software for breast cancer MRIs,” said Paragon Biosciences Chairman and CEO Jeff Aronin. “We are entering an exciting time where advances in supercomputing and machine learning make it possible for artificial intelligence to deliver on its promise for drug discovery, drug development, and diagnostics.”
     
    Paragon’s capabilities and investment in Qlarity Imaging provide the company with the working capital needed to further develop and implement its computer-aided diagnosis system and explore expanded uses of AI-enabled diagnostic tools. Paragon Biosciences advises its portfolio companies on how to leverage AI technology to enhance the diagnostic insight of medical devices, accelerate the pace of drug development, and increase the efficacy of novel therapies.
     
    Qlarity’s AI-enabled image processing and diagnostic algorithms are based on decades of research by professor of Radiology Dr. Maryellen Giger, a pioneer in the field of computer-aided diagnosis. Now an advisor to Qlarity Imaging, Dr. Giger has conducted over 30 years of research in computer-aided diagnosis, including computer vision and machine learning for breast cancer, lung cancer, prostate cancer, lupus, and bone diseases.
     
    “When we looked at how to best commercialize and scale QuantX, the computer-aided diagnostic system originally developed at the University of Chicago, Paragon Biosciences was the perfect partner,” Dr. Giger said. “Paragon is already delivering on its promise, helping Qlarity Imaging to expand its management team, pursue new product opportunities, extend its customer base, and seek additional venture financing.”
     
    With the announcement, Qlarity Imaging becomes the third portfolio company launched by Paragon Biosciences in less than a year and the seventh launched since 2017. Over the last 19 months, Paragon Biosciences and its financial partners have invested and committed over $500 million to help Paragon’s portfolio companies develop innovative therapies and diagnostic tools.
     
    Paragon Biosciences anticipates innovating, investing in, and launching additional portfolio companies this year and next.
     
    Paragon is a life science innovator that invests in, builds, and advises bioscience companies. Its mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Paragon’s portfolio of independently run bioscience companies focus on: biopharmaceuticals, AI-enabled life science products, and advanced treatments such as cell and gene therapies. We help people live longer, healthier lives.
     
    Qlarity Imaging improves patient care by building AI-driven products that provide clinical insights radiologists do not have access to today. One of Qlarity’s initial products, QuantX Advanced, is the first FDA-cleared, computer-aided diagnosis software for radiology. QuantX integrates images from multiple modalities to assist radiologists in the assessment and characterization of breast abnormalities.

     
    Related Searches
    • radiology
    • technology
    • fda clearance
    • analytics
    Suggested For You
    FDA OKs GE Healthcare FDA OKs GE Healthcare's AI-Powered Chest X-ray
    OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN
    Level Ex Receives Prestigious Grant Level Ex Receives Prestigious Grant
    AI Tool Identifies Cancer Outcomes Using Radiology Reports AI Tool Identifies Cancer Outcomes Using Radiology Reports
    Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers
    Medica 2019—Sports Medicine Conference Preview Medica 2019—Sports Medicine Conference Preview
    PATH Develops Ethical Guidelines on the Use of AI in Healthcare PATH Develops Ethical Guidelines on the Use of AI in Healthcare
    Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics
    Third FDA Clearance for Zebra-Med Third FDA Clearance for Zebra-Med's AI Solution for Brain Bleeds Alerts
    FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial
    FDA OKs Neonatal Indication for Masimo FDA OKs Neonatal Indication for Masimo's O3 Regional Oximetry
    FDA OKs ControlRad FDA OKs ControlRad's Radiation Reduction Technology that Integrates into Mobile C-arms
    FDA Clears Masimo FDA Clears Masimo's Radius PPG, the First Tetherless SET Pulse Oximetry Sensor Solution
    FDA OKs World FDA OKs World's First AI Solution for Flagging Pulmonary Embolism
    World World's First AI Chest X-Ray Triage Product Wins FDA Nod

    Related Breaking News

    • Diagnostics | Software & IT
      FDA OKs GE Healthcare

      FDA OKs GE Healthcare's AI-Powered Chest X-ray

      Helps radiologists prioritize critical cases with a suspected pneumothorax—a type of collapsed lung.
      GE Healthcare 09.12.19

    • OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN

      OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN

      Smart scanner is designed to scan and analyze tissue at the same time.
      Business Wire 09.11.19

    • Digital Health
      Level Ex Receives Prestigious Grant

      Level Ex Receives Prestigious Grant

      Will help NASA improve medical care during missions.
      Business Wire 08.08.19


    • Diagnostics | Digital Health | Software & IT
      AI Tool Identifies Cancer Outcomes Using Radiology Reports

      AI Tool Identifies Cancer Outcomes Using Radiology Reports

      Dana-Farber's AI tool performed comparably to trained human "curators" in detecting the presence of cancer.
      Dana-Farber Cancer Institute 07.26.19

    • Cardiovascular | Software & IT
      Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers

      Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers

      Technology can save time and increase access to stroke treatments.
      Medtronic 07.22.19

    Loading, Please Wait..

    Trending
    • Victoria Carr-Brendel Joins Vicarious Surgical Board
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • InBody Supplying U.S. Marine Corps With Body Composition Analysis Devices
    • The Future Of Biomedical Engineering Advancements
    • Tessy Plastics Corp. Celebrates 50th Anniversary
    Breaking News
    • Getinge iCast Receives FDA Premarket Approval
    • Tessy Plastics Corp. Celebrates 50th Anniversary
    • Carium Expands Customization Options with Care Pathways
    • InBody Supplying U.S. Marine Corps With Body Composition Analysis Devices
    • Blackford and Brainomix Collaborate to Improve Stroke Care
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    Coatings World

    Latest Breaking News From Coatings World

    HOFFMANN MINERAL to Focus on Comprehensive Sustainability Strategy
    HMG and Prodrive Renew Technical Partnership
    Eastern Coatings Show Sets Schedule for Technical Papers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge iCast Receives FDA Premarket Approval
    Tessy Plastics Corp. Celebrates 50th Anniversary
    Carium Expands Customization Options with Care Pathways
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Willow, Suanfarma Complete Manufacturing Process for Cannabigerol
    Berkshire Sterile to Install nearly 1,500 solar panels at Massachusetts site
    Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Interpack 2023 Introduces New Special Areas and Activities
    eSalon Expands into Over 1,900 CVS Stores Nationwide
    The RealReal Discontinues Beauty Business
    Happi

    Latest Breaking News From Happi

    Inolex Launches Sustainable BTAC Replacement AminoSensyl Ultra MB
    A New Way To Measure Skin Barrier Function: Research
    P&G Patents Laundry Scent Additive
    Ink World

    Latest Breaking News From Ink World

    Eastern Coatings Show Announces Schedule for Technical Papers
    Pulse Roll Label Products Adds Sean Labas to Technical Sales Team
    Amcor, Nfinite Enter into Agreement on Recyclable Packaging
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI announces 2022 Eugene Singer Award winners
    Pulse Roll Label Products expands technical sales team
    Mark Andy introduces ProWORX Label Suite
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Heartland Polymers Begins Production in Alberta
    Zeta Polimeri Becomes Radici EcoMaterials
    Responsible Flushing Alliance Holds Annual Meeting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AI is Effective at Documenting Orthopedic Encounters in Hand Surgery
    3D LifePrints Rebrands to Insight Surgery & Launches New Business in Houston
    Companion Spine Closes $60.1 Million Series A Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Midsummer, UCLA Collaborate on Perovskite-CIGS Tandem Solar Cells
    HID Reports on Reshaping the Security Industry
    Meyers Introduces New Function47 Division

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login